DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2244747/adicet-bio-acet-loses-16-39-in-4-weeks-here-s-why-a-trend-reversal-may-be-around-the-corner?cid=CS-ZC-FT-tale_of_the_tape|rsi-2244747 Mar 22, 2024 - The heavy selling pressure might have exhausted for Adicet Bio (ACET) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal. 0

https://seekingalpha.com/article/4679785-tela-bio-inc-tela-q4-2023-earnings-call-transcript?source=feed_sector_transcripts Mar 21, 2024 - TELA Bio, Inc. (NASDAQ:NASDAQ:TELA) Q4 2023 Earnings Conference Call March 21, 2024 4:30 PM ETCompany ParticipantsLouisa Smith - Vice President, Gilmartin... 0

https://www.zacks.com/stock/news/2244443/tela-bio-inc-tela-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2244443 Mar 21, 2024 - TELA Bio (TELA) delivered earnings and revenue surprises of -20.45% and 2.09%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://seekingalpha.com/news/4082227-bayer-back-boundless-bio-sets-terms-for-100m-ipo?source=feed_sector_healthcare Mar 21, 2024 - Bayer-backed Boundless Bio (BOLD), an oncology drug developer, has set terms for a proposed $100M initial public offering. Read more here. 0

https://www.zacks.com/stock/news/2244067/wall-street-analysts-think-annovis-bio-anvs-could-surge-211-71-read-this-before-placing-a-bet?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2244067 Mar 21, 2024 - The mean of analysts' price targets for Annovis Bio (ANVS) points to a 211.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. 0

https://seekingalpha.com/news/4081841-2seventy-bio-appoints-eli-casdin-and-charles-newton-to-its-board-of-directors?source=feed_sector_healthcare Mar 20, 2024 - 2seventy bio (TSVT) announces the appointment of Eli Casdin and Charles Newton to its board of directors. 0

https://www.fool.com/investing/2024/03/18/why-bluebird-bio-stock-flew-higher-than-the-market/?source=iedfolrf0000001 Mar 18, 2024 - The company was thrown a financial lifeline. 0

https://www.zacks.com/stock/news/2241353/are-medical-stocks-lagging-adicet-bio-acet-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2241353 Mar 15, 2024 - Here is how Adicet Bio, Inc. (ACET) and Adma Biologics (ADMA) have performed compared to their sector so far this year. 0

https://www.zacks.com/stock/news/2240226/allogene-allo-inks-deal-with-arbor-bio-for-crispr-technology?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2240226 Mar 13, 2024 - Allogene (ALLO) intends to combine its next generation AlloCAR T platform with Arbor Biotechnologies' proprietary CRISPR gene therapy technology to develop therapies for autoimmune diseases. 0

https://www.fool.com/investing/2024/03/13/is-bluebird-bio-stock-a-buy-now/?source=iedfolrf0000001 Mar 13, 2024 - Are you feeling brave? 0